{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T16:51:03Z","timestamp":1794243063827,"version":"4.9.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2018,7,25]],"date-time":"2018-07-25T00:00:00Z","timestamp":1532476800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drugs Aging"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1007\/s40266-018-0566-y","type":"journal-article","created":{"date-parts":[[2018,7,25]],"date-time":"2018-07-25T03:17:31Z","timestamp":1532488651000},"page":"719-734","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":147,"title":["Pharmacological Interventions to Improve Muscle Mass, Muscle Strength and Physical Performance in Older People: An Umbrella Review of Systematic Reviews and Meta-analyses"],"prefix":"10.1007","volume":"35","author":[{"name":"the Sarcopenia Guidelines Development group of the Belgian Society of Gerontology and Geriatrics (BSGG)","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3681-2807","authenticated-orcid":false,"given":"Anton","family":"De Spiegeleer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Beckw\u00e9e","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivan","family":"Bautmans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirko","family":"Petrovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,7,25]]},"reference":[{"issue":"6","key":"566_CR1","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1038\/nrcardio.2017.51","volume":"14","author":"S Haehling von","year":"2017","unstructured":"von Haehling S, Ebner N, dos Santos MR, Springer J, Anker AD. Muscle wasting and cachexia in heart failure: mechanisms and therapies. Nat Rev Cardiol. 2017;14(6):323\u201341.","journal-title":"Nat Rev Cardiol."},{"issue":"4","key":"566_CR2","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1093\/ageing\/afq034","volume":"39","author":"AJ Cruz-Jentoft","year":"2010","unstructured":"Cruz-Jentoft AJ, Baeyens JP, Bauer JM, Boirie Y, Cederholm T, Landi F, et al. Sarcopenia: European consensus on definition and diagnosis. Age Ageing. 2010;39(4):412\u201323.","journal-title":"Age Ageing."},{"issue":"3","key":"566_CR3","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.cger.2011.03.006","volume":"27","author":"M Visser","year":"2011","unstructured":"Visser M, Schaap LA. Consequences of sarcopenia. Clin Geriatr Med. 2011;27(3):387\u201399.","journal-title":"Clin Geriatr Med."},{"issue":"1","key":"566_CR4","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1093\/bmb\/ldq008","volume":"95","author":"MV Narici","year":"2010","unstructured":"Narici MV, Maffulli N. Sarcopenia: characteristics, mechanisms and functional significance. Br Med Bull. 2010;95(1):139\u201359.","journal-title":"Br Med Bull."},{"issue":"6","key":"566_CR5","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1507\/endocrj.EJ15-0154","volume":"62","author":"T Urano","year":"2015","unstructured":"Urano T, Inoue S. Recent genetic discoveries in osteoporosis, sarcopenia and obesity. Endocr J. 2015;62(6):475\u201384.","journal-title":"Endocr J."},{"key":"566_CR6","doi-asserted-by":"publisher","first-page":"b2700","DOI":"10.1136\/bmj.b2700","volume":"339","author":"A Liberati","year":"2009","unstructured":"Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gotzsche PC, Ioannidis JP, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ. 2009;339:b2700.","journal-title":"BMJ."},{"issue":"1","key":"566_CR7","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1186\/s13643-016-0384-4","volume":"5","author":"M Ouzzani","year":"2016","unstructured":"Ouzzani M, Hammady H, Fedorowicz Z, Elmagarmid A. Rayyan\u2014a web and mobile app for systematic reviews. Syst Rev. 2016;5(1):210.","journal-title":"Syst Rev."},{"key":"566_CR8","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/1471-2288-7-10","volume":"7","author":"BJ Shea","year":"2007","unstructured":"Shea BJ, Grimshaw JM, Wells GA, Boers M, Andersson N, Hamel C, et al. Development of AMSTAR: a measurement tool to assess the methodological quality of systematic reviews. BMC Med Res Methodol. 2007;7:10.","journal-title":"BMC Med Res Methodol."},{"issue":"11","key":"566_CR9","doi-asserted-by":"publisher","first-page":"1652","DOI":"10.2522\/ptj.20130627","volume":"94","author":"TM Austin","year":"2014","unstructured":"Austin TM, Richter RR, Sebelski CA. Introduction to the GRADE approach for guideline development: considerations for physical therapist practice. Phys Ther. 2014;94(11):1652\u20139.","journal-title":"Phys Ther."},{"issue":"1","key":"566_CR10","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.maturitas.2015.03.014","volume":"82","author":"P Anagnostis","year":"2015","unstructured":"Anagnostis P, Dimopoulou C, Karras S, Lambrinoudaki I, Goulis DG. Sarcopenia in post-menopausal women: Is there any role for vitamin D? Maturitas. 2015;82(1):56\u201364.","journal-title":"Maturitas."},{"issue":"6","key":"566_CR11","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1093\/ageing\/afh201","volume":"33","author":"SE Borst","year":"2004","unstructured":"Borst SE. Interventions for sarcopenia and muscle weakness in older people. Age Ageing. 2004;33(6):548\u201355.","journal-title":"Age Ageing."},{"issue":"3","key":"566_CR12","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1111\/j.1365-2605.2010.01093.x","volume":"34","author":"MD O\u2019Connell","year":"2011","unstructured":"O\u2019Connell MD, Tajar A, Roberts SA, Wu FC. Do androgens play any role in the physical frailty of ageing men? Int JAndrol. 2011;34(3):195\u2013211.","journal-title":"Int JAndrol."},{"issue":"11","key":"566_CR13","doi-asserted-by":"publisher","first-page":"1666","DOI":"10.1111\/j.1532-5415.2006.00938.x","volume":"54","author":"KJ Ottenbacher","year":"2006","unstructured":"Ottenbacher KJ, Ottenbacher ME, Ottenbacher AJ, Acha AA, Ostir GV. Androgen treatment and muscle strength in elderly men: a meta-analysis. J Am Geriatr Soc. 2006;54(11):1666\u201373.","journal-title":"J Am Geriatr Soc."},{"issue":"3","key":"566_CR14","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1007\/s12020-014-0315-x","volume":"47","author":"E Poggiogalle","year":"2014","unstructured":"Poggiogalle E, Migliaccio S, Lenzi A, Donini LM. Treatment of body composition changes in obese and overweight older adults: insight into the phenotype of sarcopenic obesity. Endocrine. 2014;47(3):699\u2013716.","journal-title":"Endocrine."},{"issue":"6","key":"566_CR15","doi-asserted-by":"publisher","first-page":"1817","DOI":"10.1007\/s00198-017-3980-9","volume":"28","author":"C Beaudart","year":"2017","unstructured":"Beaudart C, Dawson A, Shaw SC, Harvey NC, Kanis JA, Binkley N, et al. Nutrition and physical activity in the prevention and treatment of sarcopenia: systematic review. Osteoporos Int. 2017;28(6):1817\u201333.","journal-title":"Osteoporos Int."},{"issue":"9","key":"566_CR16","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1007\/s40266-015-0288-3","volume":"32","author":"LS Zhou","year":"2015","unstructured":"Zhou LS, Xu LJ, Wang XQ, Huang YH, Xiao Q. Effect of angiotensin-converting enzyme inhibitors on physical function in elderly subjects: a systematic review and meta-analysis. Drugs Aging. 2015;32(9):727\u201335.","journal-title":"Drugs Aging."},{"issue":"4","key":"566_CR17","first-page":"1077","volume":"28","author":"A Vasquez-Morales","year":"2013","unstructured":"Vasquez-Morales A, Wanden-Berghe C, Sanz-Valero J. Exercise and nutritional supplements; effects of combined use in people over 65\u00a0years; a systematic review. Nutr Hosp. 2013;28(4):1077\u201384.","journal-title":"Nutr Hosp."},{"issue":"12","key":"566_CR18","doi-asserted-by":"publisher","first-page":"E1927","DOI":"10.1210\/jc.2013-2820","volume":"98","author":"L Ceglia","year":"2013","unstructured":"Ceglia L, Niramitmahapanya S, Morais MD, Rivas DA, Harris SS, Bischoff-Ferrari H, et al. A randomized study on the effect of vitamin D-3 supplementation on skeletal muscle morphology and vitamin D receptor concentration in older women. J Clin Endocrinol Metab. 2013;98(12):E1927\u201335.","journal-title":"J Clin Endocrinol Metab."},{"key":"566_CR19","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.jnutbio.2017.02.024","volume":"46","author":"A Chanet","year":"2017","unstructured":"Chanet A, Salles J, Guillet C, Giraudet C, Berry A, Patrac V, et al. Vitamin D supplementation restores the blunted muscle protein synthesis response in deficient old rats through an impact on ectopic fat deposition. J Nutr Biochem. 2017;46:30\u20138.","journal-title":"J Nutr Biochem."},{"issue":"1","key":"566_CR20","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/jhn.12394","volume":"30","author":"H Rosendahl-Riise","year":"2017","unstructured":"Rosendahl-Riise H, Spielau U, Ranhoff AH, Gudbrandsen OA, Dierkes J. Vitamin D supplementation and its influence on muscle strength and mobility in community-dwelling older persons: a systematic review and meta-analysis. J Hum Nutr Diet. 2017;30(1):3\u201315.","journal-title":"J Hum Nutr Diet."},{"key":"566_CR21","doi-asserted-by":"crossref","unstructured":"Avenell A, Mak JCS, O\u2019Connell D. Vitamin D and vitamin D analogues for preventing fractures in post-menopausal women and older men. Cochrane Database Syst Rev. 2014;(4):CD000227.","DOI":"10.1002\/14651858.CD000227.pub4"},{"key":"566_CR22","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.jsbmb.2017.03.018","volume":"173","author":"B Dawson-Hughes","year":"2017","unstructured":"Dawson-Hughes B. Vitamin D and muscle function. J Steroid Biochem Mol Biol. 2017;173:313\u20136.","journal-title":"J Steroid Biochem Mol Biol."},{"key":"566_CR23","doi-asserted-by":"publisher","first-page":"40593","DOI":"10.1038\/srep40593","volume":"7","author":"MZ Zhang","year":"2017","unstructured":"Zhang MZ, Zhao LJ, Zhou Y, Badr R, Watson P, Ye A, et al. SNP rs11185644 of RXRA genes identified for dose-response variability to vitamin D3 supplementation: a randomized clinical trial. Sci Rep. 2017;7:40593.","journal-title":"Sci Rep."},{"key":"566_CR24","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.bone.2015.04.029","volume":"78","author":"R Takiar","year":"2015","unstructured":"Takiar R, Lutsey PL, Zhao D, Guallar E, Schneider ALC, Grams ME, et al. The associations of 25-hydroxyvitamin D levels, vitamin D binding protein gene polymorphisms, and race with risk of incident fracture-related hospitalization: Twenty-year follow-up in a bi-ethnic cohort (the ARIC Study). Bone. 2015;78:94\u2013101.","journal-title":"Bone."},{"issue":"10","key":"566_CR25","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1093\/gerona\/glp082","volume":"64","author":"SM Greising","year":"2009","unstructured":"Greising SM, Baltgalvis KA, Lowe DA, Warren GL. Hormone therapy and skeletal muscle strength: a meta-analysis. J Gerontol A Biol Sci Med Sci. 2009;64(10):1071\u201381.","journal-title":"J Gerontol A Biol Sci Med Sci."},{"issue":"2","key":"566_CR26","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1097\/gme.0b013e3181ba56c7","volume":"17","author":"YL Michael","year":"2010","unstructured":"Michael YL, Gold R, Manson JE, Keast EM, Cochrane BB, Woods NF, et al. Hormone therapy and physical function change among older women in the Women\u2019s Health Initiative: a randomized controlled trial. Menopause. 2010;17(2):295\u2013302.","journal-title":"Menopause."},{"issue":"6","key":"566_CR27","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1111\/j.1532-5415.2011.03410.x","volume":"59","author":"WL Baker","year":"2011","unstructured":"Baker WL, Karan S, Kenny AM. Effect of dehydroepiandrosterone on muscle strength and physical function in older adults: a systematic review. J Am Geriatr Soc. 2011;59(6):997\u20131002.","journal-title":"J Am Geriatr Soc."},{"issue":"2","key":"566_CR28","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1530\/EJE-10-0009","volume":"163","author":"G Gotherstrom","year":"2010","unstructured":"Gotherstrom G, Elbornsson M, Stibrant-Sunnerhagen K, Bengtsson BA, Johannsson G, Svensson J. Muscle strength in elderly adults with GH deficiency after 10\u00a0years of GH replacement. Eur J Endocrinol. 2010;163(2):207\u201315.","journal-title":"Eur J Endocrinol."},{"issue":"4","key":"566_CR29","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1210\/jc.2008-0632","volume":"94","author":"HK White","year":"2009","unstructured":"White HK, Petrie CD, Landschulz W, MacLean D, Taylor A, Lyles K, et al. Effects of an oral growth hormone secretagogue in older adults. J Clin Endocrinol Metab. 2009;94(4):1198\u2013206.","journal-title":"J Clin Endocrinol Metab."},{"issue":"12","key":"566_CR30","doi-asserted-by":"publisher","first-page":"6325","DOI":"10.1210\/jc.2004-0430","volume":"89","author":"JD Veldhuis","year":"2004","unstructured":"Veldhuis JD, Patrie JT, Frick K, Weltman JY, Weltman A. Sustained growth hormone (GH) and insulin-like growth factor I responses to prolonged high-dose twice-daily GH-releasing hormone stimulation in middle-aged and older men. J Clin Endocrinol Metab. 2004;89(12):6325\u201330.","journal-title":"J Clin Endocrinol Metab."},{"issue":"5","key":"566_CR31","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1530\/eje.1.02019","volume":"153","author":"JD Veldhuis","year":"2005","unstructured":"Veldhuis JD, Patrie JM, Frick K, Weltman JY, Weltman AL. Administration of recombinant human GHRH-1,44-amide for 3\u00a0months reduces abdominal visceral fat mass and increases physical performance measures in postmenopausal women. Eur J Endocrinol. 2005;153(5):669\u201377.","journal-title":"Eur J Endocrinol."},{"issue":"7","key":"566_CR32","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1093\/gerona\/gls258","volume":"68","author":"AP Marsh","year":"2013","unstructured":"Marsh AP, Shea MK, Locke RMV, Miller ME, Isom S, Miller GD, et al. Resistance training and pioglitazone lead to improvements in muscle power during voluntary weight loss in older adults. J Gerontol A Biol Sci Med Sci. 2013;68(7):828\u201336.","journal-title":"J Gerontol A Biol Sci Med Sci."},{"issue":"4","key":"566_CR33","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1111\/jdi.12606","volume":"8","author":"T Yokota","year":"2017","unstructured":"Yokota T, Kinugawa S, Hirabayashi K, Suga T, Takada S, Omokawa M, et al. Pioglitazone improves whole-body aerobic capacity and skeletal muscle energy metabolism in patients with metabolic syndrome. J Diabetes Investig. 2017;8(4):535\u201341.","journal-title":"J Diabetes Investig."},{"issue":"7","key":"566_CR34","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1056\/NEJMoa1506119","volume":"374","author":"PJ Snyder","year":"2016","unstructured":"Snyder PJ, Bhasin S, Cunningham GR, Matsumoto AM, Stephens-Shields AJ, Cauley JA, et al. Effects of testosterone treatment in older men. N Engl J Med. 2016;374(7):611\u201324.","journal-title":"N Engl J Med."},{"issue":"2","key":"566_CR35","first-page":"583","volume":"102","author":"TW Storer","year":"2017","unstructured":"Storer TW, Basaria S, Traustadottir T, Harman SM, Pencina K, Li ZY, et al. Effects of testosterone supplementation for 3 Years on muscle performance and physical function in older men. J Clin Endocrinol Metab. 2017;102(2):583\u201393.","journal-title":"J Clin Endocrinol Metab."},{"issue":"5","key":"566_CR36","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1177\/1074248417691136","volume":"22","author":"AM Traish","year":"2017","unstructured":"Traish AM, Haider A, Haider KS, Doros G, Saad F. Long-term testosterone therapy improves cardiometabolic function and reduces risk of cardiovascular disease in men with hypogonadism: a real-life observational registry study setting comparing treated and untreated (control) groups. J Cardiovasc Pharmacol Ther. 2017;22(5):414\u201333.","journal-title":"J Cardiovasc Pharmacol Ther."},{"issue":"1","key":"566_CR37","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.mayocp.2017.11.006","volume":"93","author":"A Elagizi","year":"2018","unstructured":"Elagizi A, Kohler TS, Lavie CJ. Testosterone and cardiovascular health. Mayo Clin Proc. 2018;93(1):83\u2013100.","journal-title":"Mayo Clin Proc."},{"issue":"4","key":"566_CR38","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1080\/17843286.2016.1168064","volume":"71","author":"A Spiegeleer De","year":"2016","unstructured":"De Spiegeleer A, Petrovic M, Boeckxstaens P, Van den Noortgate N. Treating sarcopenia in clinical practice: where are we now? Acta Clin Belg. 2016;71(4):197\u2013205.","journal-title":"Acta Clin Belg."},{"issue":"6","key":"566_CR39","doi-asserted-by":"publisher","first-page":"1991","DOI":"10.1210\/jc.2008-2338","volume":"94","author":"FR Sattler","year":"2009","unstructured":"Sattler FR, Castaneda-Sceppa C, Binder EF, Schroeder ET, Wang Y, Bhasin S, et al. Testosterone and growth hormone improve body composition and muscle performance in older men. J Clin Endocrinol Metab. 2009;94(6):1991\u20132001.","journal-title":"J Clin Endocrinol Metab."},{"issue":"2","key":"566_CR40","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1210\/jc.2005-0957","volume":"91","author":"MG Giannoulis","year":"2006","unstructured":"Giannoulis MG, Sonksen PH, Umpleby M, Breen L, Pentecost C, Whyte M, et al. The effects of growth hormone and\/or testosterone in healthy elderly men: a randomized controlled trial. J Clin Endocrinol Metab. 2006;91(2):477\u201384.","journal-title":"J Clin Endocrinol Metab."},{"issue":"4","key":"566_CR41","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1378\/chest.13-2483","volume":"146","author":"D Shrikrishna","year":"2014","unstructured":"Shrikrishna D, Tanner RJ, Lee JY, Natanek A, Lewis A, Murphy PB, et al. A randomized controlled trial of angiotensin-converting enzyme inhibition for skeletal muscle dysfunction in COPD. Chest. 2014;146(4):932\u201340.","journal-title":"Chest."},{"issue":"11","key":"566_CR42","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1007\/s40266-016-0396-8","volume":"33","author":"D Spira","year":"2016","unstructured":"Spira D, Walston J, Buchmann N, Nikolov J, Demuth I, Steinhagen-Thiessen E, et al. Angiotensin-converting enzyme inhibitors and parameters of sarcopenia: relation to muscle mass, strength and function: data from the Berlin Aging Study-II (BASE-II). Drugs Aging. 2016;33(11):829\u201337.","journal-title":"Drugs Aging."},{"issue":"1","key":"566_CR43","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s13063-017-2390-9","volume":"19","author":"MM Band","year":"2018","unstructured":"Band MM, Sumukadas D, Struthers AD, Avenell A, Donnan PT, Kemp PR, et al. Leucine and ACE inhibitors as therapies for sarcopenia (LACE trial): study protocol for a randomised controlled trial. Trials. 2018;19(1):6.","journal-title":"Trials."},{"issue":"6","key":"566_CR44","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1093\/gerona\/glt142","volume":"69","author":"D Sumukadas","year":"2014","unstructured":"Sumukadas D, Band M, Miller S, Cvoro V, Witham M, Struthers A, et al. Do ACE inhibitors improve the response to exercise training in functionally impaired older adults? A randomized controlled trial. J Gerontol A Biol Sci Med Sci. 2014;69(6):736\u201343.","journal-title":"J Gerontol A Biol Sci Med Sci."},{"key":"566_CR45","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1210\/jc.2004-1184","volume":"90","author":"S Bhasin","year":"2005","unstructured":"Bhasin S, Woodhouse L, Casaburi R, Singh AB, Mac RP, Lee M, et al. Older men are as responsive as young men to the anabolic effects of graded doses of testosterone on the skeletal muscle. J Clin Endocrinol Metab. 2005;90:678\u201388.","journal-title":"J Clin Endocrinol Metab."},{"key":"566_CR46","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1210\/jc.2009-1251","volume":"95","author":"U Srinivas-Shankar","year":"2010","unstructured":"Srinivas-Shankar U, Roberts SA, Connolly MJ, O\u2019Connell MDL, Adams JE, Oldham JA, et al. Effects of testosterone on muscle strength, physical function, body composition, and quality of life in intermediate-frail and frail elderly men: a randomized, double-blind, placebo-controlled study. J Clin Endocrinol Metab. 2010;95:639\u201350.","journal-title":"J Clin Endocrinol Metab."}],"container-title":["Drugs & Aging"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40266-018-0566-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40266-018-0566-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40266-018-0566-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,24]],"date-time":"2019-07-24T19:07:49Z","timestamp":1563995269000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40266-018-0566-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,25]]},"references-count":46,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2018,8]]}},"alternative-id":["566"],"URL":"https:\/\/doi.org\/10.1007\/s40266-018-0566-y","relation":{},"ISSN":["1170-229X","1179-1969"],"issn-type":[{"value":"1170-229X","type":"print"},{"value":"1179-1969","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,7,25]]},"assertion":[{"value":"25 July 2018","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"No sources of funding were used to conduct this study or prepare this manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"Anton De Spiegeleer, David Beckw\u00e9e, Ivan Bautmans and Mirko Petrovic have no conflicts of interest that are directly relevant to the content of this review.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}